MYX — Mycelx Technologies Income Statement
0.000.00%
Last trade - 00:00- £5.60m
- £4.05m
- $10.91m
- 30
- 34
- 10
- 12
Annual income statement for Mycelx Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 11.9 | 7.1 | 8.48 | 10 | 10.9 |
| Cost of Revenue | |||||
| Gross Profit | 6.09 | 1.59 | 3.27 | 4.44 | 3.89 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 14.3 | 12.8 | 9.58 | 13.6 | 14.2 |
| Operating Profit | -2.41 | -5.65 | -1.1 | -3.57 | -3.33 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -2.5 | -5.77 | -1.13 | -3.57 | -3.34 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.96 | -6.09 | -1.43 | -3.99 | -3.71 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.96 | -6.09 | -1.43 | -3.99 | -3.71 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.96 | -6.09 | -1.43 | -3.99 | -3.71 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.153 | -0.327 | -0.173 | -0.18 | -0.161 |